ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION

ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION

Show other versions (1)

<p><strong>Aim.</strong> To estimate antihypertensive, organ protective and metabolic efficiency of angiotensin converting enzyme (ACE) inhibitor spirapril in patients with arterial hypertension (AH).</p><p><strong>Material and methods.</strong> 30 patients...

Full description

Bibliographic Details
Main Authors:	M. V. Leonova, M. A. Demidova, A. V. Tarasov, Y. V. Belousov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-12-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	артериальная гипертензия спираприл эндотелиальная функция нефропротекция липиды метаболизм глюкозы
Online Access:	http://www.rpcardio.ru/jour/article/view/346

Similar Items

ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2015-09-01)

Antihypertensive spirapril effectiveness in patients with mild to moderate arterial hypertension
by: M. M. Beraya, et al.
Published: (1970-01-01)

Spirapril – a modern ACE inhibitor
by: V. M. Gorbunov
Published: (2005-06-01)

Dynamics of lipid profile and circadian pressure rhythms in patients with obesity and arterial hypertension, treated with orlistat and its combination with ACE inhibitors
by: A. G. Avtandilov, et al.
Published: (2005-02-01)

CLINICAL IMPORTANCE OF ENDOTHELIAL DYSFUNCTION AND INSULIN RESISTANCE SYNDROME IN PATIENTS WITH GOUT ASSOCIATED WITH ARTERIAL HYPERTENSION
by: N. N. Kushnarenko, et al.
Published: (2015-09-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND NEPHROPROTECTION: PLACE OF OLMESARTAN
by: V. V. Fomin
Published: (2013-08-01)

THE PREDICTION OF HYPERTENSION IN MINERS
by: T. A. Mulerova, et al.
Published: (2014-06-01)

Endothelial dysfunction and apoptosis in the pathogenesis of cognitive impairment in patients with arterial hypertension
by: M. V. Ivanov, et al.
Published: (2009-02-01)

Pleiotropic effects of antihypertensive therapy variants
by: S. V. Malchikova, et al.
Published: (2009-04-01)

ACE inhibitor spirapril effects on circadian blood pressure profile, quality of life, and psychological status in patients with Stage I-II arterial hypertension
by: V. M. Gorbunov, et al.
Published: (2008-12-01)

Effects of fluvastatin, valsartan, and their combination on endothelial function in patients with arterial hypertension and dyslipidemia
by: T. Sh. Mirilashvili, et al.
Published: (2009-08-01)

Pharmaco-economical analysis of Russian QUADRIGA Study data
by: A. A. Kuprina, et al.
Published: (2006-04-01)

Vasoprotection and nephroprotection: links of the same chain
by: N. Sh. Zagidullin, et al.
Published: (1970-01-01)

SOME FEATURES OF HUMAN LIPID AND CARBOHYDRATE METABOLISM IN THE NORTH
by: Ye. V. Sevostyanova
Published: (2013-02-01)

Endothelial dysfunction in hypertension: cause or effect?
by: A. Yu. Gorshkov, et al.
Published: (2019-12-01)

Endothelial functional activity and circadian blood pressure dynamics in hypertensive patients treated with angiotensin receptor antagonists
by: N. G. Poteshkina, et al.
Published: (2011-10-01)

ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION
by: M. V. Leonova, et al.
Published: (2015-12-01)

Body weight dynamics and cardiovascular risk factors in climacteric women
by: A. A. Popov, et al.
Published: (1970-01-01)

Ramipril and amlodipine therapy effects on endothelial vasodilatation, metabolic profile, and arterial hypertension course in women with postmenopausal metabolic syndrome
by: A. R. Ishmanova, et al.
Published: (2010-02-01)

ФУНКЦИОНАЛЬНОЕ СОСТОЯНИЕ ЭНДОТЕЛИЯ СОСУДОВ ПРИ ГИПЕРГОМОЦИСТЕИНЕМИИ У ДЕТЕЙ С АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ
by: А. В. Лукша, et al.
Published: (2023-03-01)

Arterial hypertension in tuberculosis patients: clinical course and pharmaceutical control
by: N. Yu. Klimenko, et al.
Published: (2007-10-01)

ASSESSMENT OF AMLODIPINE ANTIHYPERTENSIVE EFFECT HOMOGENEITY IN CONTROLLED TRIAL
by: V. M. Gorbunov, et al.
Published: (2016-01-01)

RENAL DENERVATION IN RESISTANT ARTERIAL HYPERTENSION
by: V. A. Sulimov, et al.
Published: (2015-09-01)

Moexipril in postmenopausal women with arterial hypertension
by: M. G. Glezer, et al.
Published: (2005-02-01)

Rilmenidine therapy potential in pharmaceutical correction of endothelial dysfunction among women with arterial hypertension, Type 2 diabetes mellitus, and visceral obesity
by: E. V. Eliseeva, et al.
Published: (1970-01-01)

Nifedipine and losartan effects on endothelial function during acute pharmacological test in arterial hypertension patients with various risk factors
by: M. O. Argunova, et al.
Published: (2008-02-01)

Clinical efficiency of medium and high doses of valsartan in the treatment of patient with arterial hypertension and chronic kidney diseases
by: M L Maximov, et al.
Published: (2010-12-01)

Angiotensin II receptor antagonist valsartan in treatment of patients with arterial hypertension and chronic kidney diseases. Hypotensive and nephroprotective efficacy
by: M L Maximov, et al.
Published: (2010-09-01)

Vliyanie narusheniya metabolizma glyukozy na techenie i iskhod ostrogo ishemicheskogo insul'ta
by: Lyudmila Alexandrovna Chugunova, et al.
Published: (2007-12-01)

Comparative effectiveness of spirapril and enalapril in patients with coronary heart disease-caused chronic heart failure
by: S, Yu. Volkova, et al.
Published: (2006-08-01)

DISRUPTIONS OF ELASTIC ARTERIES PROPERTIES AND ENDOTHELIAL FUNCTION: MODERN METHODS FOR CORRECTION AND PREVENTION
by: A. F. Kolpakova
Published: (2015-06-01)

EFFECTS OF AMLODIPINE, FOSINOPRIL AND METOPROLOL ON HEMODYNAMICS IN HYPERTENSIVE PATIENTS
by: A. L. Hohlov, et al.
Published: (2015-12-01)

МОНИТОРИНГ ТЕЧЕНИЯ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ У ЖЕНЩИН, ПРОЖИВАЮЩИХ В УСЛОВИЯХ ХОЛОДНОГО КЛИМАТА
by: Донская А.А., et al.
Published: (2022-06-01)

Characteristics of cardiac contractile function changes in combined model of experimental arterial hypertension and acute coronary insufficiency after treatment with calcium channel blockers
by: K Y Kasem, et al.
Published: (2009-12-01)

Obesity and arterial hypertension. Part II: features of antihypertensive therapy in obese patients
by: S. V. Nedogoda, et al.
Published: (2009-02-01)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
by: L. N. Chikhireva, et al.
Published: (2015-12-01)

ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION OF VALSARTAN AND VALSARTAN AND HYDROCHLOROTHIAZIDE COMBINATION IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Rosuvastatin in patients with arterial hypertension and dyslipidemia: effects on microcirculation and pulse wave parameters
by: O. M. Drapkina, et al.
Published: (2012-12-01)

Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy
by: L. I. Abasova, et al.
Published: (2011-08-01)

Nefroprotektivnyy effekt antigipertenzivnoy terapii: issledovanie IRIS
by: L G Ratova, et al.
Published: (2004-06-01)